Hanna Berglund

[¹⁶¹Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma

Chopra, Saloni; Xu, Tianqi; Berglund, Hanna; Gustafsson, Amanda et al.

Ingår i EJNMMI Research, 2026

• DOI för [¹⁶¹Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma
• Ladda ner fulltext (pdf) av [¹⁶¹Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma

Preclinical Validation of [¹⁷⁷Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human Trials

Mortensen, Anja C. L.; Mohajershojai, Tabassom; Gustafsson, Amanda; Berglund, Hanna et al.

Ingår i Journal of Nuclear Medicine, s. 269-275, 2026

• DOI för Preclinical Validation of [¹⁷⁷Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human Trials
• Ladda ner fulltext (pdf) av Preclinical Validation of [¹⁷⁷Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human Trials

Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy

Uffenorde, Julia; Hariri, Mehran; Papalanis, Eleftherios; Staffas, Annika et al.

Ingår i Frontiers in Oncology, 2025

• DOI för Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy
• Ladda ner fulltext (pdf) av Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy

Dual targeting of G9a and DNMTs induces antitumor effects in multiple myeloma

Nylund, Patrick; Garrido-Zabala, Berta; Tziola, Stefania Iliana; Mohajershojai, Tabassom et al.

Ingår i Blood Advances, s. 4825-4841, 2025

• DOI för Dual targeting of G9a and DNMTs induces antitumor effects in multiple myeloma
• Ladda ner fulltext (pdf) av Dual targeting of G9a and DNMTs induces antitumor effects in multiple myeloma

Dual-Nuclide Biodistribution and Therapeutic Evaluation of a Novel Antibody-Based Radiopharmaceutical in Anaplastic Thyroid Cancer Xenografts

Mortensen, Anja; Berglund, Hanna; Jha, Preeti; Stenman, Adam et al.

Ingår i Molecular Cancer Therapeutics, s. 753-762, 2025

• DOI för Dual-Nuclide Biodistribution and Therapeutic Evaluation of a Novel Antibody-Based Radiopharmaceutical in Anaplastic Thyroid Cancer Xenografts
• Ladda ner fulltext (pdf) av Dual-Nuclide Biodistribution and Therapeutic Evaluation of a Novel Antibody-Based Radiopharmaceutical in Anaplastic Thyroid Cancer Xenografts

[¹⁶¹Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma

Chopra, Saloni; Xu, Tianqi; Berglund, Hanna; Gustafsson, Amanda et al.

Ingår i EJNMMI Research, 2026

• DOI för [¹⁶¹Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma
• Ladda ner fulltext (pdf) av [¹⁶¹Tb]Tb-DOTATATE as a potential treatment option for neuroblastoma

Preclinical Validation of [¹⁷⁷Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human Trials

Mortensen, Anja C. L.; Mohajershojai, Tabassom; Gustafsson, Amanda; Berglund, Hanna et al.

Ingår i Journal of Nuclear Medicine, s. 269-275, 2026

• DOI för Preclinical Validation of [¹⁷⁷Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human Trials
• Ladda ner fulltext (pdf) av Preclinical Validation of [¹⁷⁷Lu]Lu-AKIR001, a CD44v6-Targeted Radiotherapeutic Entering First-in-Human Trials

Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy

Uffenorde, Julia; Hariri, Mehran; Papalanis, Eleftherios; Staffas, Annika et al.

Ingår i Frontiers in Oncology, 2025

• DOI för Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy
• Ladda ner fulltext (pdf) av Enhancing glioblastoma therapy: unveiling synergistic anticancer effects of Onalespib - radiotherapy combination therapy

Dual targeting of G9a and DNMTs induces antitumor effects in multiple myeloma

Nylund, Patrick; Garrido-Zabala, Berta; Tziola, Stefania Iliana; Mohajershojai, Tabassom et al.

Ingår i Blood Advances, s. 4825-4841, 2025

• DOI för Dual targeting of G9a and DNMTs induces antitumor effects in multiple myeloma
• Ladda ner fulltext (pdf) av Dual targeting of G9a and DNMTs induces antitumor effects in multiple myeloma

Dual-Nuclide Biodistribution and Therapeutic Evaluation of a Novel Antibody-Based Radiopharmaceutical in Anaplastic Thyroid Cancer Xenografts

Mortensen, Anja; Berglund, Hanna; Jha, Preeti; Stenman, Adam et al.

Ingår i Molecular Cancer Therapeutics, s. 753-762, 2025

• DOI för Dual-Nuclide Biodistribution and Therapeutic Evaluation of a Novel Antibody-Based Radiopharmaceutical in Anaplastic Thyroid Cancer Xenografts
• Ladda ner fulltext (pdf) av Dual-Nuclide Biodistribution and Therapeutic Evaluation of a Novel Antibody-Based Radiopharmaceutical in Anaplastic Thyroid Cancer Xenografts

p53 stabilisation potentiates [¹⁷⁷Lu]Lu-DOTATATE treatment in neuroblastoma xenografts

Berglund, Hanna; Lundsten Salomonsson, Sara; Mohajershojai, Tabassom; Ferrer Gago, Fernando Jose et al.

Ingår i European Journal of Nuclear Medicine and Molecular Imaging, s. 768-778, 2024

• DOI för p53 stabilisation potentiates [¹⁷⁷Lu]Lu-DOTATATE treatment in neuroblastoma xenografts
• Ladda ner fulltext (pdf) av p53 stabilisation potentiates [¹⁷⁷Lu]Lu-DOTATATE treatment in neuroblastoma xenografts

Selection, characterization and in vivo evaluation of novel CD44v6-targeting antibodies for targeted molecular radiotherapy

Mortensen, Anja; Berglund, Hanna; Segerström, Lova; Walle, M. et al.

Ingår i Scientific Reports, 2023

• DOI för Selection, characterization and in vivo evaluation of novel CD44v6-targeting antibodies for targeted molecular radiotherapy
• Ladda ner fulltext (pdf) av Selection, characterization and in vivo evaluation of novel CD44v6-targeting antibodies for targeted molecular radiotherapy

Combination therapy of tyrosine kinase inhibitor sorafenib with the HSP90 inhibitor onalespib as a novel treatment regimen for thyroid cancer

Lundgren Mortensen, Anja Charlotte; Berglund, Hanna; Hariri, Mehran; Papalanis, Eleftherios et al.

Ingår i Scientific Reports, 2023

• DOI för Combination therapy of tyrosine kinase inhibitor sorafenib with the HSP90 inhibitor onalespib as a novel treatment regimen for thyroid cancer
• Ladda ner fulltext (pdf) av Combination therapy of tyrosine kinase inhibitor sorafenib with the HSP90 inhibitor onalespib as a novel treatment regimen for thyroid cancer

Maternal prenatal depressive symptoms and toddler behavior: an umbilical cord blood epigenome-wide association study

Kunovac Kallak, Theodora; Fransson, Emma; Bränn, Emma; Berglund, Hanna et al.

Ingår i Translational Psychiatry, 2022

• DOI för Maternal prenatal depressive symptoms and toddler behavior: an umbilical cord blood epigenome-wide association study
• Ladda ner fulltext (pdf) av Maternal prenatal depressive symptoms and toddler behavior: an umbilical cord blood epigenome-wide association study

p53-Mediated Radiosensitization of ¹⁷⁷Lu-DOTATATE in Neuroblastoma Tumor Spheroids

Lundsten, Sara; Berglund, Hanna; Jha, Preeti; Krona, Cecilia et al.

Ingår i Biomolecules, 2021

• DOI för p53-Mediated Radiosensitization of ¹⁷⁷Lu-DOTATATE in Neuroblastoma Tumor Spheroids
• Ladda ner fulltext (pdf) av p53-Mediated Radiosensitization of ¹⁷⁷Lu-DOTATATE in Neuroblastoma Tumor Spheroids

To a Radiant Future and Beyond: Improving Radiotherapy of Neuroblastoma

Berglund, Hanna

2025

• Ladda ner fulltext (pdf) av To a Radiant Future and Beyond: Improving Radiotherapy of Neuroblastoma

Therapeutic combination of HSP90 inhibition and radiation therapy reduces tumor growth in a syngeneic neuroblastoma mouse model.

Berglund, Hanna; Pereira, Beatriz; Nestor, Marika; Spiegelberg, Diana